Australian Clinical Labs Ltd (AU:ACL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Australian Clinical Labs Ltd has a new substantial shareholder as KKR Entities, consisting of Comet Asia Holdings and others, acquired a 5.05% voting power with over 10 million fully paid ordinary shares. This development signifies increased interest from prominent investment groups in the company’s stock, possibly influencing its market value and investor sentiment.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.